Healthcare & Life Sciences
COUR Pharmaceuticals
United Statescourpharmaceuticals.com
COUR Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About COUR Pharmaceuticals
Based in the United States, COUR Pharmaceuticals is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
COUR Pharmaceuticals develops nanoparticle therapies that deliver disease-specific antigens or allergens to antigen-presenting cells in the spleen and liver via natural, non-inflammatory phagocytic pathways to modulate the immune system.
Explore COUR Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.